Carbohydrate Derived Fulvic Acid for the Treatment of Vulvovaginal Candidiasis

Carbohydrate Derived Fulvic Acid for the Treatment of Vulvovaginal Candidiasis

AIM: To evaluate the efficacy of carbohydrate derived fulvic acid (CHD-FA) against clinical isolates of Candida species causing vulvovaginal candidiasis (VVC). BACKGROUND: Therapeutic failure in the treatment of VVC is common and new, effective treatment options need to be developed. CHD-FA is a mix...

Full description

Saved in:

Bibliographic Details
Main Authors:	Stewart Clark, Michael Graz
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	Journal of Global Antimicrobial Resistance
Subjects:	Carbohydrate Derived Fulvic Acid Vulvovaginal Candidiasis Candida
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213716524003801
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Population level of main microbiota and yeast-like Candida fungi in women with vulvovaginal candidiasis
by: N. D. Yakovychuk, et al.
Published: (2017-06-01)

Estimation of Immunoglobulins and complements and Using Enzyme linked Immuno sorbant Assay in Identification of Vulvovaginal candidiasis
by: Baghdad Science Journal
Published: (2009-09-01)

The Burden of Vulvovaginal Candidiasis Among Women in Developing Countries: A Systematic Review
by: Sule, H. , Kumurya, A. S. and Ahmad I. A.
Published: (2019-03-01)

Vulvovaginal Candidiasis Among Women with Bacterial Vaginosis Attending Aminu Kano Teaching Hospital, Nigeria
by: Sule, H.*, Kumurya, A.S., Nasir, A.
Published: (2018-03-01)

Genetic susceptibility to recurrent vulvovaginal candidiasis in an African population from Nairobi, Kenya
by: Gloria S. Omosa-Manyonyi, et al.
Published: (2025-04-01)

Identification of Candida species Isolated From Vulvovaginal Candidiasis Patients by Chromgen agar and PCR-RFLP Method
by: Baghdad Science Journal
Published: (2016-06-01)

The Prevalence of Non-albicans Candida and Candida Mixed-species in Vulvovaginal Candidiasis in Northeast Iran
by: Batoul Jannati, et al.
Published: (2024-03-01)

Vaginal Royal Jelly for Vulvovaginal Candidiasis Treatment: A Randomized Clinical Trial
by: Maryam Ramazany Chaleshtori, et al.
Published: (2025-04-01)

Differential PCR diagnosis of bacterial vaginosis, aerobic vaginitis and vulvovaginal candidiasis
by: T. I. Makhova, et al.
Published: (2022-06-01)

Synergistic Inhibition of <i>Candida albicans</i> by Cranberry Proanthocyanidins and Probiotics: Novel Strategies for Vulvovaginal Candidiasis Treatment
by: Yu-Ru Wu, et al.
Published: (2025-03-01)

Candidiasis mucocutánea: espectro clínico
by: Claudia Patricia Palacios, et al.
Published: (2019-03-01)

Efficacy and safety of vaginal suppositories containing combination of Natamycin and Lactulose in treatment of vulvovaginal candidiasis: international, randomized, controlled, superiority clinical trial (combination of Natamycin and Lactulose for treatment of vulvovaginal candidiasis)
by: Oksana N. Volkova, et al.
Published: (2025-02-01)

Blue light-emitting diode: a new adjuvant approach to conventional treatment of recurrent vulvovaginal candidiasis
by: Isadora Bastiani Biondo, et al.
Published: (2025-08-01)

In vitro antifungal activities of some mushroom extracts against yeast isolates among women with vulvovaginal candidiasis in a teaching hospital
by: Adewale Oke, et al.
Published: (2025-06-01)

Risk factors for recurrent vulvovaginal candidiasis
by: Janković Slobodan, et al.
Published: (2010-01-01)

Carbohydrate-derived fulvic acid wellness drink: its tolerability, safety and effect on disease markers in pre-ART HIV-1 positive subjects
by: M. E. Botes, et al.
Published: (2018-07-01)

Species Distribution, Characterization, and Antifungal Susceptibility Patterns of <i>Candida</i> Isolates Causing Oral and Vulvovaginal Candidiasis in Chile
by: Francisca Nahuelcura, et al.
Published: (2025-07-01)

Effects of intravaginal curcumin gels combined with electroporation on vulvovaginal candidiasis
by: Yizhi Zhang, et al.
Published: (2025-01-01)

New insights toward personalized therapies for vulvovaginal candidiasis and vaginal co-infections
by: Francesco De Seta, et al.
Published: (2025-08-01)

AI-assisted diagnosis of vulvovaginal candidiasis using cascaded neural networks
by: Zhongxiao Wang, et al.
Published: (2025-01-01)

Dual Mechanisms of Action: Anti-Candida and Anti-Inflammatory Potential of <i>Lactobacillus</i> Fermentation Broth in Treating Vulvovaginal Candidiasis
by: Huann-Cheng Horng, et al.
Published: (2024-12-01)

Microbiological reasoning of the formation and development of vulvovaginal candidiasis
by: N. D. Yakovychuk, et al.
Published: (2017-08-01)

Effect of Some predisposing factors on Vulvovaginal Candidiasis
by: Baghdad Science Journal
Published: (2010-09-01)

Recent advances in vulvovaginal Candidiasis research: A narrative review
by: Debasmita Dubey, et al.
Published: (2023-11-01)

Symptomatic vulvovaginal candidiasis and antifungal resistance in HIV-1 positive women at Mbarara city health centre IV
by: Nusifah Mbatudde, et al.
Published: (2025-07-01)

Molecular biological characteristics of Candida albicans strains causing recurrent vulvovaginal candidiasis with different susceptibility to antifungal drugs in vitro
by: Venchakova V.V., et al.
Published: (2025-03-01)

Pathogenetic aspects and modern possibilities of therapy of vulvovaginal candidiasis
by: Margarita R. Rakhmatulina, et al.
Published: (2024-12-01)

New insights in the role of Candida biofilm in the pathogenesis of recurrent vulvovaginal candidiasis: a prospective clinical study
by: Marta Díaz-Navarro, et al.
Published: (2025-03-01)

Molecular epidemiology of Nakaseomyces glabrata associated with vulvovaginal candidiasis revealed high genetic variability and the presence of novel genotypes in China
by: Xue Xu, et al.
Published: (2025-12-01)

Bioactive Potential of Chitosan–Oleic Acid Nanoparticles Loaded with Lemon Peel Essential Oil for Topical Treatment of Vulvovaginal Candidiasis
by: Faten M. Ibrahim, et al.
Published: (2024-12-01)

Phenotypic characterization and antifungal susceptibility profile of Candida isolates from women with vulvovaginal candidiasis at a community health center linked to a teaching institution in the Sub-Himalayan region of North India
by: Sangeeta Rawat, et al.
Published: (2023-12-01)

Isolation, identification and antifungal susceptibility of Candida species in postmenopausal women
by: Sally Abdul Mohsen, et al.
Published: (2024-12-01)

Impacto de la terapia intravaginal con nistatina/dexametasona en la calidad de vida relacionada con la salud de mujeres con vulvovaginitis candidiásica o mixta
by: Martin Emilio Romero Prada, et al.
Published: (2025-02-01)

Fulvic Acid: an Active Food Additive or Medication?
by: N. S. Benderskii, et al.
Published: (2020-06-01)

Prevalence and Changing Virulence Factors and Biofilm Formation among Non-Albicans Candida Species in Suspected Vulvovaginitis Infections
by: Rahul Gopichand Walide1*, et al.
Published: (2024-12-01)

Lactic acid in the vaginal milieu modulates the Candida-host interaction
by: Diletta Rosati, et al.
Published: (2025-12-01)

Antifungal susceptibility testing and determination of local epidemiological cut-off values for Candida species isolated from women with vulvovaginal candidiasis
by: Vasiliki Kroustali, et al.
Published: (2025-03-01)

A Fungistatic Strategy Using a Shear-Thinning pH-Responsive CMCS-OHA-Lp/Lr Hydrogel for Vulvovaginal Candidiasis
by: Yuanmin Zhao, et al.
Published: (2025-04-01)

Prevalence of vulvovaginal candidiasis among pregnant women in Akwa Ibom State, Nigeria
by: Peace Icha, et al.
Published: (2025-08-01)

The Effect of Fulvic Acid on Alzheimer's Disease - A Systematic Review
by: Kornelia Kaźmierkiewicz, et al.
Published: (2025-05-01)